Advertisement
Screener

LEXARIA BIOSCIENCE CORP. (LEXX) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

LEXARIA BIOSCIENCE CORP. Operating Expenses

LEXARIA BIOSCIENCE CORP. (LEXX) reported Operating Expenses of $1.99 million for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-07-13

  • LEXARIA BIOSCIENCE CORP. operating expenses for the quarter ending 2026-05-31 was $1.99M, a 49.19% decline year-over-year.
  • LEXARIA BIOSCIENCE CORP. operating expenses for the quarter ending 2026-02-28 was $1.47M, a 49.68% decline year-over-year.
  • LEXARIA BIOSCIENCE CORP. operating expenses for the quarter ending 2025-11-30 was $1.57M, a 45.21% decline year-over-year.
  • LEXARIA BIOSCIENCE CORP. operating expenses for the quarter ending 2025-08-31 was $2.86M, a 25.16% increase year-over-year.
  • LEXARIA BIOSCIENCE CORP. operating expenses for fiscal 2025 was $12.58M, a 102.56% increase from fiscal 2024.
  • LEXARIA BIOSCIENCE CORP. operating expenses for fiscal 2024 was $6.21M, a 7.67% decline from fiscal 2023.
  • LEXARIA BIOSCIENCE CORP. operating expenses for fiscal 2023 was $6.73M, a 1.09% decline from fiscal 2022.
  • LEXARIA BIOSCIENCE CORP. operating expenses for fiscal 2022 was $6.80M, a 9.12% increase from fiscal 2021.
Period endOperating Expenses 2 monthOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 10 monthOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-05-31$1.99M
10-Q · filed 2026-07-13
$3.47M
derived: sum of 2 quarters · filed 2026-07-13
$5.04M
10-Q · filed 2026-07-13
$7.90M
derived: sum of 4 quarters · filed 2026-07-13
2026-02-28$1.47M
10-Q · filed 2026-04-13
$3.05M
10-Q · filed 2026-04-13
$5.91M
derived: sum of 3 quarters · filed 2026-04-13
$9.83M
derived: sum of 4 quarters · filed 2026-07-13
2025-11-30$1.57M
10-Q · filed 2026-01-13
$4.44M
derived: sum of 2 quarters · filed 2026-01-13
$8.36M
derived: sum of 3 quarters · filed 2026-07-13
$11.29M
derived: sum of 4 quarters · filed 2026-07-13
2025-08-31$2.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28
$6.79M
derived: sum of 2 quarters · filed 2026-07-13
$9.71M
derived: sum of 3 quarters · filed 2026-07-13
$12.58M
10-K · filed 2025-11-28
2025-05-31$3.92M
10-Q · filed 2026-07-13
$6.85M
derived: sum of 2 quarters · filed 2026-07-13
$9.72M
10-Q · filed 2026-07-13
$12.01M
derived: sum of 4 quarters · filed 2026-07-13
2025-02-28$2.93M
10-Q · filed 2026-04-13
$5.80M
10-Q · filed 2026-04-13
$8.08M
derived: sum of 3 quarters · filed 2026-04-13
$9.91M
derived: sum of 4 quarters · filed 2026-04-13
2024-11-30$2.87M
10-Q · filed 2026-01-13
$5.16M
derived: sum of 2 quarters · filed 2026-01-13
$6.99M
derived: sum of 3 quarters · filed 2026-01-13
$7.80M
derived: sum of 4 quarters · filed 2026-01-13
2024-08-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28
$4.11M
derived: sum of 2 quarters · filed 2025-11-28
$4.93M
derived: sum of 3 quarters · filed 2025-11-28
$6.21M
10-K · filed 2025-11-28
2024-05-31$1.83M
10-Q · filed 2025-07-14
$2.64M
derived: sum of 2 quarters · filed 2025-07-14
$3.93M
10-Q · filed 2025-07-14
$5.07M
derived: sum of 4 quarters · filed 2025-07-14
2024-02-29$813.00K
10-Q · filed 2025-04-14
$2.10M
10-Q · filed 2025-04-14
$3.24M
derived: sum of 3 quarters · filed 2025-04-14
$5.71M
derived: sum of 4 quarters · filed 2025-04-14
2023-11-30$1.29M
10-Q · filed 2025-01-10
$2.43M
derived: sum of 2 quarters · filed 2025-01-10
$4.90M
derived: sum of 3 quarters · filed 2025-01-10
$6.24M
derived: sum of 4 quarters · filed 2025-01-10
2023-08-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26
$3.61M
derived: sum of 2 quarters · filed 2024-11-26
$4.95M
derived: sum of 3 quarters · filed 2024-11-26
$6.73M
10-K · filed 2024-11-26
2023-05-31$2.47M
10-Q · filed 2024-07-12
$2.46M
10-Q · filed 2023-07-14
$3.81M
derived: sum of 2 quarters · filed 2024-07-12
$5.58M
10-Q · filed 2024-07-12
$5.66M
10-Q · filed 2023-07-14
$6.40M
derived: sum of 4 quarters · filed 2024-07-12
2023-02-28$1.34M
10-Q · filed 2024-04-09
$1.34M
10-Q · filed 2023-04-14
$3.12M
10-Q · filed 2024-04-09
$3.20M
10-Q · filed 2023-04-14
$3.94M
derived: sum of 3 quarters · filed 2024-04-09
$6.44M
derived: sum of 4 quarters · filed 2024-04-09
2022-11-30$1.78M
10-Q · filed 2024-01-12
$1.85M
10-Q · filed 2023-01-17
$2.60M
derived: sum of 2 quarters · filed 2024-01-12
$5.10M
derived: sum of 3 quarters · filed 2024-01-12
$6.57M
derived: sum of 4 quarters · filed 2024-01-12
2022-08-31$818.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20
$3.32M
derived: sum of 2 quarters · filed 2023-11-20
$4.79M
derived: sum of 3 quarters · filed 2023-11-20
$6.80M
10-K · filed 2023-11-20
$7.57M
10-K · filed 2022-11-28
2022-05-31$2.50M
10-Q · filed 2023-07-14
$3.97M
derived: sum of 2 quarters · filed 2023-07-14
$5.98M
10-Q · filed 2023-07-14
$7.30M
derived: sum of 4 quarters · filed 2023-07-14
2022-02-28$1.47M
10-Q · filed 2023-04-14
$3.48M
10-Q · filed 2023-04-14
$4.80M
derived: sum of 3 quarters · filed 2023-04-14
$7.51M
derived: sum of 4 quarters · filed 2023-04-14
2021-11-30$2.01M
10-Q/A · filed 2023-01-18
$3.33M
derived: sum of 2 quarters · filed 2023-01-18
$6.04M
derived: sum of 3 quarters · filed 2023-01-18
$7.30M
derived: sum of 4 quarters · filed 2023-01-18
2021-08-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28
$4.02M
derived: sum of 2 quarters · filed 2022-11-28
$5.29M
derived: sum of 3 quarters · filed 2022-11-28
$6.23M
10-K · filed 2022-11-28
2021-05-31$2.71M
10-Q · filed 2022-07-14
$3.98M
derived: sum of 2 quarters · filed 2022-07-14
$4.92M
10-Q · filed 2022-07-14
$3.40M
10-Q · filed 2021-07-15
$5.83M
derived: sum of 4 quarters · filed 2022-07-14
2021-02-28$1.27M
10-Q · filed 2022-04-11
-$256.75K
10-Q · filed 2021-04-14
$2.21M
10-Q · filed 2022-04-11
$687.54K
10-Q · filed 2021-04-14
$3.12M
derived: sum of 3 quarters · filed 2022-04-11
$4.55M
derived: sum of 4 quarters · filed 2022-04-11
2020-11-30$944.30K
10-Q · filed 2021-01-14
$1.86M
derived: sum of 2 quarters · filed 2021-11-29
$3.28M
derived: sum of 3 quarters · filed 2021-11-29
$4.33M
derived: sum of 4 quarters · filed 2021-11-29
2020-08-31$913.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29
$2.34M
derived: sum of 2 quarters · filed 2021-11-29
$3.38M
derived: sum of 3 quarters · filed 2021-11-29
$4.36M
10-K · filed 2021-11-29
$4.37M
10-K · filed 2020-10-15
2020-05-31$1.43M
10-Q · filed 2021-07-15
$1.45M
10-Q · filed 2020-06-29
$2.47M
derived: sum of 2 quarters · filed 2021-07-15
$3.45M
10-Q · filed 2021-07-15
$3.48M
10-Q · filed 2020-06-29
$4.67M
derived: sum of 4 quarters · filed 2021-07-15
2020-02-29$1.04M
10-Q · filed 2021-04-14
$1.05M
10-Q · filed 2020-04-03
$2.02M
10-Q · filed 2021-04-14
$2.03M
10-Q · filed 2020-04-03
$3.25M
derived: sum of 3 quarters · filed 2021-04-14
$4.49M
derived: sum of 4 quarters · filed 2021-04-14
2019-11-30$978.59K
10-Q · filed 2021-01-14
$978.99K
10-Q · filed 2020-01-09
$2.20M
derived: sum of 2 quarters · filed 2021-01-14
$3.45M
derived: sum of 3 quarters · filed 2021-01-14
$4.62M
derived: sum of 4 quarters · filed 2021-01-14
2019-08-31$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15
$2.47M
derived: sum of 2 quarters · filed 2020-10-15
$3.64M
derived: sum of 3 quarters · filed 2020-10-15
$4.36M
10-K · filed 2020-10-15
2019-05-31$1.24M
10-Q · filed 2020-06-29
$2.41M
derived: sum of 2 quarters · filed 2020-06-29
$3.13M
10-Q · filed 2020-06-29
$4.45M
derived: sum of 4 quarters · filed 2020-06-29
2019-02-28$1.17M
10-Q · filed 2020-04-03
$1.89M
10-Q · filed 2020-04-03
$3.21M
derived: sum of 3 quarters · filed 2020-04-03
$6.77M
derived: sum of 4 quarters · filed 2020-04-03
2018-11-30$721.44K
10-Q · filed 2020-01-09
$2.04M
derived: sum of 2 quarters · filed 2020-01-09
$5.60M
derived: sum of 3 quarters · filed 2020-01-09
$7.14M
derived: sum of 4 quarters · filed 2020-01-09
2018-08-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14
$4.88M
derived: sum of 2 quarters · filed 2019-11-14
$6.42M
derived: sum of 3 quarters · filed 2019-11-14
$7.02M
10-K · filed 2019-11-14
2018-05-31$3.56M
10-Q · filed 2019-07-08
$5.10M
derived: sum of 2 quarters · filed 2019-07-08
$5.70M
10-Q · filed 2019-07-08
$6.42M
derived: sum of 4 quarters · filed 2019-07-08
2018-02-28$1.54M
10-Q · filed 2019-04-15
$2.13M
10-Q · filed 2019-04-15
$2.86M
derived: sum of 3 quarters · filed 2019-04-15
$3.23M
derived: sum of 4 quarters · filed 2019-04-15
2017-11-30$597.25K
10-Q · filed 2019-01-11
$1.32M
derived: sum of 2 quarters · filed 2019-01-11
$1.69M
derived: sum of 3 quarters · filed 2019-01-11
$2.15M
derived: sum of 4 quarters · filed 2019-01-11
2017-08-31$727.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14
$1.09M
derived: sum of 2 quarters · filed 2018-11-14
$1.55M
derived: sum of 3 quarters · filed 2018-11-14
$1.96M
10-K · filed 2018-11-14
2017-05-31$364.16K
10-Q · filed 2018-07-13
$826.87K
derived: sum of 2 quarters · filed 2018-07-13
$1.24M
10-Q · filed 2018-07-13
$1.57M
derived: sum of 4 quarters · filed 2018-11-14
2017-02-28$462.71K
10-Q · filed 2018-04-12
$871.60K
10-Q · filed 2018-04-12
$1.20M
derived: sum of 3 quarters · filed 2018-11-14
$1.47M
derived: sum of 4 quarters · filed 2018-11-14
2016-11-30$408.89K
10-Q · filed 2018-01-12
$741.51K
derived: sum of 2 quarters · filed 2018-11-14
$1.00M
derived: sum of 3 quarters · filed 2018-11-14
$1.27M
derived: sum of 4 quarters · filed 2018-11-14
2016-08-31$332.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14
$593.73K
derived: sum of 2 quarters · filed 2018-11-14
$864.20K
derived: sum of 3 quarters · filed 2018-11-14
$1.27M
10-K · filed 2018-11-14
2016-05-31$261.11K
10-Q · filed 2017-07-14
$531.58K
derived: sum of 2 quarters · filed 2017-07-14
$939.73K
10-Q · filed 2017-07-14
$1.54M
derived: sum of 4 quarters · filed 2017-07-14
2016-02-29$270.47K
10-Q · filed 2017-04-14
$678.62K
10-Q · filed 2017-04-14
$1.28M
derived: sum of 3 quarters · filed 2017-04-14
$1.79M
derived: sum of 4 quarters · filed 2017-04-14
2015-11-30$408.15K
10-Q · filed 2017-01-13
$1.01M
derived: sum of 2 quarters · filed 2017-01-13
$1.52M
derived: sum of 3 quarters · filed 2017-01-13
$1.98M
derived: sum of 4 quarters · filed 2017-01-13
2015-08-31$602.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29
$1.11M
derived: sum of 2 quarters · filed 2016-11-29
$1.57M
derived: sum of 3 quarters · filed 2016-11-29
$1.97M
10-K · filed 2016-11-29
2015-05-31$508.50K
10-Q · filed 2016-07-13
$967.94K
derived: sum of 2 quarters · filed 2016-07-13
$1.37M
10-Q · filed 2016-07-13
$2.13M
derived: sum of 4 quarters · filed 2016-07-13
2015-02-28$459.44K
10-Q · filed 2016-04-13
$857.51K
10-Q · filed 2016-04-13
$1.62M
derived: sum of 3 quarters · filed 2016-04-13
2014-11-30$398.07K
10-Q · filed 2016-01-08
$1.16M
derived: sum of 2 quarters · filed 2016-01-08
2014-08-31$762.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27
$1.56M
10-KT · filed 2014-12-09
$1.56M
10-K · filed 2015-11-27
2014-07-31$621.72K
10-Q · filed 2014-11-14
$1.31M
10-Q · filed 2014-11-14
2014-05-31$527.68K
10-Q · filed 2015-07-14
$797.16K
10-Q · filed 2015-07-14
2014-04-30$550.87K
10-Q · filed 2014-06-12
$686.15K
10-Q · filed 2014-06-12
2014-02-28$127.71K
10-Q · filed 2015-04-14
$269.48K
10-Q · filed 2015-04-14
2014-01-31$135.28K
10-Q · filed 2014-03-12
2013-11-30$141.76K
10-Q · filed 2015-01-14
2013-10-31$626.51K
10-KT · filed 2014-12-09
$135.75K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24
$269.57K
derived: sum of 2 quarters · filed 2014-11-14
$405.40K
derived: sum of 3 quarters · filed 2014-11-14
$645.80K
10-K · filed 2014-01-24
2013-08-31$538.33K
10-KT · filed 2014-12-09
2013-07-31$133.82K
10-Q · filed 2014-11-14
$269.64K
derived: sum of 2 quarters · filed 2014-11-14
$510.05K
10-Q · filed 2014-11-14
$682.10K
derived: sum of 4 quarters · filed 2014-11-14
2013-04-30$135.82K
10-Q · filed 2014-06-12
$376.23K
10-Q · filed 2014-06-12
$548.28K
derived: sum of 3 quarters · filed 2014-06-12
$745.29K
derived: sum of 4 quarters · filed 2014-06-12
2013-01-31$240.40K
10-Q · filed 2014-03-12
$412.46K
derived: sum of 2 quarters · filed 2014-03-12
$609.47K
derived: sum of 3 quarters · filed 2014-03-12
$843.30K
derived: sum of 4 quarters · filed 2014-03-12
2012-10-31$172.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24
$369.07K
derived: sum of 2 quarters · filed 2014-01-24
$602.90K
derived: sum of 3 quarters · filed 2014-01-24
$826.00K
10-K · filed 2014-01-24
2012-07-31$197.01K
10-Q · filed 2013-09-10
$430.85K
derived: sum of 2 quarters · filed 2013-09-10
$653.95K
10-Q · filed 2013-09-10
$817.97K
derived: sum of 4 quarters · filed 2013-09-10
2012-04-30$233.83K
10-Q · filed 2013-06-12
$456.93K
10-Q · filed 2013-06-12
$620.95K
derived: sum of 3 quarters · filed 2013-06-12
$1.05M
derived: sum of 4 quarters · filed 2013-06-12
2012-01-31$223.10K
10-Q · filed 2013-03-13
$387.12K
derived: sum of 2 quarters · filed 2013-03-13
$814.45K
derived: sum of 3 quarters · filed 2013-03-13
$1.05M
derived: sum of 4 quarters · filed 2013-03-13
2011-10-31$164.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29
$591.35K
derived: sum of 2 quarters · filed 2013-01-29
$822.92K
derived: sum of 3 quarters · filed 2013-01-29
$1.00M
10-K · filed 2013-01-29
2011-07-31$427.32K
10-Q · filed 2012-09-12
$658.90K
derived: sum of 2 quarters · filed 2012-09-12
$840.12K
10-Q · filed 2012-09-12
$974.21K
derived: sum of 4 quarters · filed 2012-09-12
2011-04-30$231.58K
10-Q · filed 2012-06-07
$412.79K
10-Q · filed 2012-06-07
$546.88K
derived: sum of 3 quarters · filed 2012-06-07
$615.83K
derived: sum of 4 quarters · filed 2012-06-07
2011-01-31$181.21K
10-Q · filed 2012-03-13
$315.31K
derived: sum of 2 quarters · filed 2012-03-13
$384.25K
derived: sum of 3 quarters · filed 2012-03-13
2010-10-31$134.10K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30
$203.04K
derived: sum of 2 quarters · filed 2012-01-30
$641.32K
10-K · filed 2012-01-30
2010-07-31$68.95K
10-Q · filed 2011-09-14
$507.22K
10-Q · filed 2011-09-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30